Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune(®) System

BACKGROUND: Tumor treating fields (TTFields) are a non-invasive antimitotic therapy that delivers alternating electric fields via the Optune(®) system. The Phase III EF-14 trial in newly diagnosed glioblastoma multiforme (GBM) showed significantly improved progression-free, overall and long-term sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinzel, Adrian, Ambrogi, Michael, Varshaver, Michael, Kirson, Eilon D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351720/
https://www.ncbi.nlm.nih.gov/pubmed/30728735
http://dx.doi.org/10.1177/1179554918825449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351720/
https://www.ncbi.nlm.nih.gov/pubmed/30728735
http://dx.doi.org/10.1177/1179554918825449

Ejemplares similares